All In Biotech

Free tool

FAERS Monitor: Fioricet W/ Codeine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020232 or its brand name (Fioricet W/ Codeine, Acetaminophen, Butalbital, Caffeine, Codeine Phosphate). Reports on generic versions are filed under their own applications.

Reports

38

Serious

35

92% of reports

Hospitalization

1

Death reported

12

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dependence27
  • overdose15
  • completed suicide5
  • death3
  • drug ineffective3
  • cardio-respiratory arrest2
  • maternal exposure during pregnancy2
  • withdrawal syndrome2
  • aggression1
  • anxiety1
  • blood testosterone decreased1
  • constipation1
  • depression1
  • drug abuse1
  • drug dependence1

Reports by year received

View as table
YearReports
20152
20161
20171
20182
20191
20202
202327
20242

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,121 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dependenceSignal27272.7222.67,056
blood testosterone decreased180.911.719
overdoseSignal1538.526.0516
completed suicideSignal533.214.7126
cardio-respiratory arrest226.56.927
withdrawal syndrome226.46.827
maternal exposure during pregnancy212.43.211
aggression111.11.62
drug abuse16.61.01
drug dependence13.40.50
constipation12.50.40
depression12.40.40
anxiety11.90.30
death31.90.71
drug ineffective31.30.40

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.